Meet with GlycoMark at AACC 2018!

Posted on July 6, 2018 by

Are you attending the American Association of Clinical Chemistry (AACC) 70th Annual Scientific Meeting & Clinical Lab Expo in August? While in Chicago, meet with GlycoMark’s management team to learn more about the GlycoMark test – the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).  To schedule time, email Kirsten@L3healthcare.com or click here.

The GlycoMark test is an FDA-cleared, non-fasting serum or plasma test for monitoring blood glucose variability in people with diabetes. The GlycoMark test provides quantitative measurement of 1,5-anhydroglucitol (1,5-AG) in serum or plasma. The test is for professional use, and is indicated for the intermediate term monitoring of glycemic control in people with diabetes.

Contact Info

  • 1-888-744-0221
  • 212-355-8165
  • 805 Third Avenue, 17th Floor
    New York, NY 10022
Copyright © 2018 Glycomark.